Why I Don’t Believe Larry Ellison’s Moderna Stock Hype
CEO Larry Ellison’s claims that artificial intelligence (AI) could help develop messenger RNA-based (mRNA) vaccines to cure ...
GEN18h
A Call to Action: Building Vaccine Trust Through Transparency
It’s time for a new era of public health—where vaccines are seen as both a scientific triumph and a shared commitment to well ...
Sick of the stomach bug? Moderna is making a norovirus vaccine
Moderna is developing an mRNA-based vaccine for norovirus, now in Phase 3 trials, with hopes of approval by 2026 to combat the highly contagious stomach virus.
Yeni Şafak6d
Experts at Davos warn of grave threat to global health from climate change
Only 23 countries use climate data for health surveillance, says head of WMO, adding more collaboration needed ...
pharmaphorum6d
Moderna and BioNTech – who are they?
CEO Stephane Bancel was hired the following year from France’s bioMerieux and Moderna went on to raise more than $2.6 billion in a series of private funding rounds, while fiercely guarding any ...
pharmaphorum3d
Moderna will cut $1.1bn off its annual R&D spend
With COVID-19 revenues now shrinking fast, Moderna chief executive Stéphane Bancel has taken the decision to rein in spending and reduce the number of active development programmes, which have ...
The Motley Fool5d
Why Moderna Stock Jumped Over 20% This Week
This is the key reason Moderna stock is in a 90% drawdown. Nevertheless, artificial intelligence (AI) developments may supercharge the mRNA vaccine industry. At least, that's what Oracle CEO Larry ...